AI assistant
Sending…
Lunai Bioworks Inc. — Director's Dealing 2017
Sep 22, 2017
34813_dirs_2017-09-22_f0d61fdc-d0bc-4da1-94b8-7effd12c4a8e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: DanDrit Biotech USA, Inc. (DDRT)
CIK: 0001527728
Period of Report: 2017-07-11
Reporting Person: Wolfe Robert (Chief Financial Officer (1))
More from Lunai Bioworks Inc.
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Capital/Financing Update
2026
May 1
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 13
Delisting Announcement
2026
Feb 23
Interim / Quarterly Report
2026
Feb 17
Delisting Announcement
2026
Feb 12